AstraZeneca and Scorpion collaborate on therapeutics against transcription factors for cancer Jan. 17, 2022
Everest Medicines licenses global rights to EDDC's 3CL protease inhibitors to treat COVID-19 Jan. 14, 2022
Hemogenyx and Selexis agree to develop cell line for Hemogenyx's CDX bispecific antibody Jan. 13, 2022
Lantern Pharma expands collaboration with NCI to support progression of LP-184 and LP-284 Jan. 13, 2022
Dren Bio and Pfizer collaborate to discover and develop bispecific antibodies for cancer Jan. 12, 2022
Amgen and Arrakis collaborate to discover and develop targeted RNA degrader therapeutics Jan. 12, 2022
RSS